Title :

Change in bacterial causes of community-acquired parapneumonic effusion and pleural empyema in children 6 years after 13-valent pneumococcal conjugate vaccine implementation

Author(s) :

Madhi, Fouad [Auteur]
Levy, Corinne [Auteur]
Morin, Laurence [Auteur]
Minodier, Philippe [Auteur]
Dubos, Francois [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Zenkhri, Ferielle [Auteur]
Dommergues, Marie-Aliette [Auteur]
Mezgueldi, Ellia [Auteur]
Levieux, Karine [Auteur]
Bechet, Stéphane [Auteur]
Varon, Emmanuelle [Auteur]
Cohen, Robert [Auteur]

Journal title :

Journal of the Pediatric Infectious Diseases Society

Abbreviated title :

J Pediatric Infect Dis Soc

Publication date :

2018-11-08

ISSN :

2048-7207

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

We describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009-2017). For 220 (39.3%) of 560 children, a ...
Show more >We describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009-2017). For 220 (39.3%) of 560 children, a bacterial cause was found. The frequency of pneumococcal infection decreased during the study from 79.1% in 2009 to 36.4% in 2017 (P < .001). Group A streptococcus is now the leading cause of documented empyema (45.5%).Show less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

CHU Lille
Université de Lille

Collections :

• METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Submission date :

2019-12-09T16:48:38Z